The FINANCIAL -- Results from THALASSA, the first pivotal placebo-controlled study examining the benefit of iron chelation with Exjade in patients with non-transfusion-dependent thalassemia, show that Exjade can significantly reduce iron overload.

The FINANCIAL -- Bayer HealthCare has submitted an application for marketing authorization in the European Union and in the U.S. for a new low dose levonorgestrel releasing intrauterine system for long-term contraception of up to three years.

The FINANCIAL -- Pharmacyclics a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer and immune mediated diseases, announced today interim results from an ongoing Phase II trial of the selective irreversible Bruton's tyrosine kinase inhibitor PCI-32765 in MCL.

The FINANCIAL -- Pfizer announced that its Board of Directors has elected current President and Chief Executive Officer, Ian Read, as Chairman of the Board and Chief Executive Officer, effective immediately.